Biotechnology's Impact on Drug Development and Vaccine Production
<p><span>Biotechnology has revolutionized drug and vaccine development, introducing innovative approaches that enable personalized and targeted treatments. With advancements in genetic sequencing, gene editing, and biomarker discovery, biotechnology offers new opportunities for improving healthcare outcomes. However, challenges such as disease complexity, regulatory approval processes, high development costs, and ethical concerns continue to hinder progress. Despite these obstacles, biotechnology holds immense promise in addressing global health issues, particularly in the development of personalized medicine and vaccines tailored to individual genetic profiles. The integration of artificial intelligence, nanotechnology, and other cutting-edge technologies is further driving advancements in drug discovery and production. Overcoming the challenges in biotechnology requires continuous research, regulatory adaptations, and international collaborations to ensure equitable access and affordability. The future of biotechnology in drug and vaccine development is promising, with the potential to transform global healthcare by providing more effective, personalized, and accessible therapies.</span></p>
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-03-06
- DOI
- https://doi.org/10.5281/zenodo.14983553
- Primary Topic
- Biotechnology and Related Fields
- Type
- article
- Field-Weighted Citation Impact
- 0.00